Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Total 13F shares
-
7,806,672
-
Share change
-
+7,806,672
-
Total reported value
-
$94,381,000
-
Price per share
-
$12.09
-
Number of holders
-
24
-
Value change
-
+$94,381,000
-
Number of buys
-
24
Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2017
As of 31 Dec 2017,
scPharmaceuticals Inc. - Common Stock (SCPH) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,806,672 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Vanguard Group Inc, Alyeska Investment Group, L.P., AWM Investment Company, Inc., Nicholas Investment Partners, LP, Bain Capital Public Equity Management, LLC, and DAFNA Capital Management LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.